Indeed, viral delivery of IGF-1 to the CNS has been shown to delay motor neuron death in SOD1G93A mice [61], although the efficacy of IGF-1-based therapy in ALS patients remains controversial [62]. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.